Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
Market Drivers & Limiters for each chapter segment
Competitive Analysis for each chapter segment
Section on recent mergers & acquisitions
The market includes both bare platinum and coated coils. Coated coils grew in popularity after their initial release as they were thought to promote faster healing and a lower rate of recanalization in the aneurysm. In recent years clinical trials, such as MAPS and Cerecyte, failed to show superiority in clinical outcomes and as a result the use of coated coils has been decreasing. There has been a recent trend towards smaller aneurysms being treated, which require fewer coils, as they are getting diagnosed earlier in their development. Approximately five coils are used per aneurysm treatment for smaller aneurysms. When aneurysms are larger than 5 mm, there will be approximately two coils used per mm of aneurysm. Unit sales will also be threatened by new technology which will cannibalize aneurysm treatment procedures. As more aneurysms are treated by new technology and those remaining use fewer coils, there will be a decrease in unit sales.
The decrease in market value for coils will therefore be driven by both fewer unit sales and price decreases, with a shift away from the use of coated coils.
Detachable coil embolization is a minimally invasive method of treating brain aneurysms and cerebral blood vessel malformations. An aneurysm is a weakened area in the wall of an artery in the brain. This area bulges in the artery and if it ruptures it can lead to a bleed in the brain and cause stroke, brain damage and even death. Interventional neuroradiologists will typically perform the detachable coil embolization process to alleviate dangers associated with aneurysms.